Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 421-425

  Bowton, David L ^a,b   Seeds, Michael C ^a   Fasano, Mary Beth ^a   Goldsmith, Barbara ^a   Bass, David A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Section on Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2; DIAGNOSTIC AGENT; METHACHOLINE CHLORIDE; PHOSPHOLIPASE A;

ALLERGIC ASTHMA; ARTICLE; BRONCHOSCOPY; FATTY ACID METABOLISM; HUMAN; HYDROLYSIS; LIPID ANALYSIS; LIPOGENESIS; LUNG EDEMA; LUNG LAVAGE; PRIORITY JOURNAL; PROVOCATION TEST; ASTHMA; CHEMISTRY; INHALATION TEST; LUNG FUNCTION TEST; MASS FRAGMENTOGRAPHY; METABOLISM;

ARACHIDONIC ACID; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METHACHOLINE CHLORIDE; PHOSPHOLIPASES A; RESPIRATORY FUNCTION TESTS;

EID: 0030614481     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032172     Document Type: Article

References (29)

1. 2 expression and inflammation: the relationship with associated disease states. J. Lipid. Mediat. 8:1-30.
2. Kim, D. K., T. Fukuda, B. T. Thompson, B. Cockrill, C. Hales, and J. V. Bonventre. 1995. Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. American Journal of Physiology-Lung Cellular & Molecular Physiology 269(1):L109-L118.
3. 2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am. Rev. Respir. Dis. 142: 157-161.
4. Toyoshima, M., A. Sato, M. Taniguchi, S. Imokawa, K. Nakazawa, H. Hayakawa, and K. Chida. 1995. Serum phospholipase A2 activity in patients with aspirin-induced asthma. Nippon Kyobu Shikkan Gakkai Zasshi-Japanese Journal of Thoracic Diseases 33:691-694.
5. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
6. Sterk, P. J., L. M. Fabbri, P. H. Quanjer, D. W. Cockcroft, P. M. O'Byrne, S. D. Anderson, E. F. Juniper, and J.-L. Malo. 1993. Airway responsiveness. Standardized challenge testing with pharmacological, physical, and sensitizing stimuli in adults. Eur. Respir. J. 6(Suppl. 16):53-83.
7. Wenzel, S. E., J. Y. Westcott, and G. L. Larsen. 1991. Bronchoalveolar lavage fluid mediator levels 5 min after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J. Allergy Clin. Immunol. 87:540-548.
8. Anonymous. 1985. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am. Rev. Respir. Dis. 132:180-182.
9. Rennard, S. I., M. Ghafouri, A. B. Thompson, J. Linder, W. Vaughan, K. Jones, R. F. Ertl, K. Christensen, A. Prince, M. G. Stahl, and R. A. Robbins. 1990. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am. Rev. Respir. Dis. 141:208-217.
10. Zehr, B. B., T. B. Casale, D. Wood, C. Floerchinger, H. B. Richerson, and G. W. Hunninghake. 1989. Use of segmental airway lavage to obtain relevant mediators from the lungs of asthmatic and control subjects. Chest 95:1059-1063.
11. Lykens, M. G., W. B. Davis, and E. R. Pacht. 1992. Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 262:L169-L175.
12. Hadley, J. S., A. Fradin, and R. C. Murphy. 1988. Electron capture negative ion chemical ionization analysis of arachidonic acid. Biomed. Environ. Mass. Spectrom. 15:175-178.
13. Kramer, R. M., and R. B. Pepinksy. 1991. Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis. Methods Enzymol. 197:373-381.
14. Schalkwijk, C. J., F. Marki, and H. Van Den Bosch. 1990. Studies on the acyl-chain selectivity of cellular phospholipases A2. Biochim. Biophys. Acta 1044:139-146.
15. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
16. Busse, W. W., W. F. Calhoun, and J. D. Sedgwick. 1993. Mechanism of airway inflammation in asthma. Am. Rev. Respir. Dis. 147:S20-S24.
17. 4 and granulocytic infiltration into asthmatic airways. Lancet 341:989-990.
18. Smith, H. R., G. L. Larsen, R. M. Cherniack, S. E. Wenzel, N. F. Voelkel, J. Y. Westcott, and R. A. Bethel. 1992. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J. Allergy Clin. Immunol. 89:1076-1084.
19. Wenzel, S. E., G. L. Larsen, K. Johnston, N. F. Voelkel, and J. Y. Westcott. 1990. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am. Rev. Respir. Dis. 142:112-119.
20. Westcott, J. Y., H. R. Smith, S. E. Wenzel, G. L. Larsen, R. B. Thomas, D. Felsien, and N. F. Voelkel. 1991. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am. Rev. Respir. Dis. 143:1322-1328.
21. Smith, C. M., P. E. Christie, R. J. Hawksworth, F. Thien, and T. H. Lee. 1991. Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma. Am. Rev. Respir. Dis. 144:1411-1413.
22. Manning, P. J., J. Rokach, J. L. Malo, D. Ethier, A. Cartier, Y. Girard, S. Charleson, and P. M. O'Byrne. 1990. Urinary leukotriene E4 levels during early and late asthmatic responses. J. Allergy Clin. Immunol. 86:211-220.
23. Fonteh, A. N., D. A. Bass, L. A. Marshall, M. Seeds, J. M. Samet, and F. H. Chilton. 1994. Evidence that secretory phospholipase A2 plays a role in arachidonate release and eicosanoid biosynthesis by mast cells. J. Immunol. 152:5438.
24. Glover, S., T. Bayburt, M. Jonas, E. Chi, and M. H. Gelb. 1995. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium inophore or IgE/antigen. J. Bio-Chem. 270:15359-15367.
25. Lindahl, M., A. R. Hede, and C. Tagesson. 1986. Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung. Exp. Lung Res. 11:1-12.
26. Niewoehner, D. E., K. Rice, A. A. Sinha, and D. Wangensteen. 1987. Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium. J. Appl. Physiol. 63:1979-1986.
27. Enhorning, G., and B. A. Holm. 1993. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J. Appl. Physiol. 74:2922-2927.
28. Enhorning, G., L. C. Duffy, and R. C. Welliver. 1995. Pulmonary surfactant maintains patency of conducting airways in the rat. Am. J. Respir. Crit. Care Med. 151:554-556.
29. Chilton, F. H., F. J. Averill, W. C. Hubbard, A. N. Fonteh, M. Triggiani, and M. C. Liu. 1996. Antigen-induced generation of lysophospholipids in human airways. J. Exp. Med. 183:1-11.